Stocks wating for FDA approval
4/25/2024 11:09am
Aime
fda approval status include pending(83)
last-price  | last-change% | FDA Approval Status | Drug Name | Indication | FDA Review Round | Accelerated Approval Status | Accelerated Approval Pathway | FDA Approval Event Type | FDA Review Date |
|---|---|---|---|---|---|---|---|---|---|
| 1.37 | 0.00 | Pending | Vafseo (Vadadustat) | Anemia, Chronic kidney disease, Kidney disease | 1 | Not Accelerated | -- | PDUFA Date | 20240327 |
| 3.94 | 0.77% | Pending | ADX-2191 (DHFR inhibitor) | Eye disease , Non-Hodgkin lymphoma, Chronic lymphocytic leukemia, Proliferative vitreoretinopathy | 1 | Accelerated | Priority Review | PDUFA Date | 20230621 |
| 143.80 | -1.55% | Pending | ONPATTRO (Patisiran) | Transthyretin amyloidosis | 1 | Not Accelerated | -- | PDUFA Date | 20231008 |
| 143.80 | -1.55% | Pending | ONPATTRO (Patisiran) | Transthyretin amyloidosis | 1 | Not Accelerated | -- | FDA Adcomm | 20230913 |
| 273.01 | -0.19% | Pending | LUMAKRAS/LUMYKRAS Copy | Non-small cell lung carcinoma | 1 | Accelerated | Accelerated Approval | FDA Adcomm | 20231005 |
| 6.05 | 12.04% | Pending | IPX203 | Parkinson disease | 1 | Not Accelerated | -- | PDUFA Date | 20230630 |
| 19.27 | 0.47% | Pending | JEMPERLI (dostarlimab-gxly) | Recurrent or Advanced dMMR/MSI-H Endometrial Cancer | 1 | Not Accelerated | -- | PDUFA Date | 20230923 |
| 3.90 | -8.88% | Pending | LIBERVANT(Diazepam) Buccal Film | Seizures | 1 | Not Accelerated | -- | PDUFA Date | 20240428 |
| 6.43 | 0.63% | Pending | XPHOZAH (Tenapanor) (Phosphate Absorption Inhibitor) | Electrolyte disorder, Hyperphosphatemia, Kidney disease, Chronic kidney disease | 1 | Not Accelerated | -- | PDUFA Date | 20231017 |
| 375.00 | -0.02% | Pending | SC Efgartigimod | MYASTHENIA GRAVIS, Autoimmune disease | 1 | Not Accelerated | -- | PDUFA Date | 20230620 |
| 143.18 | -1.14% | Pending | YORVIPATH(palopegteriparatide, developed as TransCon PTH) | Adult hypoparathyroidism | 1 | Not Accelerated | -- | PDUFA Date | 20240514 |
Ticker |
|---|
| AKBAAkebia Therapeutics |
| ALDXAldeyra Therapeutics |
| ALNYAlnylam Pharmaceuticals |
| ALNYAlnylam Pharmaceuticals |
| AMGNAmgen |
| AMRXAmneal |
| ANABAnaptysBio |
| AQSTAquestive |
| ARDXArdelyx |
| ARGXargenx |
| ASNDAscendis Pharma |
View 60 results
Continue this conversation 
Explore
Screener
Analysis
Learn
News
Wiki